ELV
Elevance Health, Inc. Health Care Hospital & Medical Service Plans S&P 500Russell 3000
$420.07Close
$92.7BMarket cap
$277.89 – $445.2852-week range
Mid-januaryNext report · estimated
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
6%
1wk
down 4.5%
price change
1mo
up 8.0%
price change
12-month return
up 32%
market up 11% ·
its own up 16%
F-score
7 / 9
Strong
Altman Z″
3.13
Low risk
P/E
16.4×
price / earnings
PEG
—
P/E / EPS growth
P/B
2.1×
price / book
Earnings yield
up 6.3%
EBIT / enterprise value
Cheaper than
66%
of the market · cheap
Revenue growth
up 12%
year on year
EPS growth
up 18%
latest quarter · +31 pts
Sales growth
up 1%
latest quarter · +0 pts
ROE
up 13%
return on equity
Free cash margin
up 2%
$3.2B FCF
D/E
0.70
long-term debt / equity
Net debt / EBITDA
2.4×
Interest cover
—EBIT / interest
Piotroski tests
- profitability slipped from last year
- profits not fully backed by cash
- profitable on its assets
- generating cash from operations
- reduced long-term debt
- short-term liquidity improved
- no new shares issued
- gross margin widened
- assets working harder
Trade setup
ATR%
2.8%
$11.55 a day · 2×ATR $396.96
RS
73 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
0.86
50 sessions
Implied move
—
no scheduled report
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 21, 2026
Results reaction
Oct 21, 2026+2% vs market2 sessions after results
Options
$526,33931.2% IV · activity
Financials
- Gross 89%
- Net 3%
- Free cash 2%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B |
| Gross margin | 93% | 92% | 92% | 90% | 89% | 89% |
| Operating income | $6.4B | $7.6B | $8.3B | $8.5B | $7.9B | $7.2B |
| Net income | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B |
| Net margin | 4% | 4% | 4% | 3% | 3% | 3% |
| Earnings per share | $17.98 | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 |
| Free cash flow | $9.7B | $7.3B | $7.2B | $6.8B | $4.6B | $3.2B |
| Free cash margin | 8% | 5% | 5% | 4% | 3% | 2% |
| Cash | $5.7B | $4.9B | $7.4B | $6.5B | $8.3B | $9.5B |
| Long-term debt | $19.3B | $21.2B | $22.3B | $23.2B | $29.2B | $30.8B |
| Shareholders' equity | $33.2B | $36.1B | $36.2B | $39.3B | $41.3B | $43.9B |
| Shares outstanding | 245.40m | 241.77m | 237.96m | 233.07m | 227.48m | 220.72m |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $394 – $446 ±6.3% by Nov 20, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 31.2% priced · 25.7% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- Choppier
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs less
Positioning
- Premium traded
- $526,339 calls $247,018 · puts $279,322 · latest session
- 1.13× +0.09 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +309 · puts +710 past week
For options traders: ATM IV 31.2% (+2.0% 1w) · 1m ÷ 3m IV 1.07 · 25Δ skew -0.3 pts · Net GEX $2.8M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 21, 2026 | Quarterly ↗ | Sep 30, 2026 | 21d |
| Jul 15, 2026 | Quarterly ↗ | Jun 30, 2026 | 15d |
| Apr 22, 2026 | Quarterly ↗ | Mar 31, 2026 | 22d |
| Feb 6, 2026 | Annual ↗ | Dec 31, 2025 | 37d |
| Oct 21, 2025 | Quarterly ↗ | Sep 30, 2025 | 21d |
| Jul 17, 2025 | Quarterly ↗ | Jun 30, 2025 | 17d |
| Apr 22, 2025 | Quarterly ↗ | Mar 31, 2025 | 22d |
| Feb 20, 2025 | Annual ↗ | Dec 31, 2024 | 51d |
| Oct 17, 2024 | Quarterly ↗ | Sep 30, 2024 | 17d |
| Jul 17, 2024 | Quarterly ↗ | Jun 30, 2024 | 17d |
| Apr 18, 2024 | Quarterly ↗ | Mar 31, 2024 | 18d |
| Feb 21, 2024 | Annual ↗ | Dec 31, 2023 | 52d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 21, 2026 | Results ↗ |
| Sep 10, 2026 | Regulation FD ↗ |
| Jul 15, 2026 | Results ↗ |
| Jun 10, 2026 | Regulation FD ↗ |
| May 13, 2026 | Shareholder vote ↗ |
| Apr 22, 2026 | Results ↗ |
| Mar 10, 2026 | Regulation FD ↗ |
| Mar 2, 2026 | Other events ↗ |
| Feb 26, 2026 | Director or officer change · Regulation FD ↗ |
| Jan 28, 2026 | Results ↗ |
| Dec 10, 2025 | Director or officer change ↗ |
| Nov 10, 2025 | Regulation FD ↗ |